Apnimed Inc. (APMD)

NasdaqGS: APMD · Echtzeitkurs · USD

29.58

+2.21 (8.07%)

Zum Schluss: Aug 28, 2026, 8:00 PM

30.30

+1.99%

Nachbörslich: 7:46 PM

Kurs, die wichtigsten Kennzahlen und die neuesten Nachrichten an einem Ort.

8.07% (1D)

Keine Daten verfügbar

Geld	31.14
Marktkapitalisierung	1.18 Mrd
Umsatz (TTM)	120.15 Mio
Nettogewinn (TTM)	39 Mio
	n/a
	3.57
	8.32
	-7.65
KBV (TTM)	-0.55
KUV (TTM)	9.85
Termin Quartalszahlen	n/a

Brief	30.31
Volumen	333,387
Ø Vol. (20D)	556,761
Eröffnung	27.59
Vortagesschluss	27.37
Tagesspanne	26.86 - 30.19
52-Wk Range	16.12 - 35.29
Analyst	n/a
Kursziel	n/a
Dividenden	n/a
Ex-Dividenden-Datum	n/a

Über APMD

Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. It offers AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts....

[Mehr lesen]

Branche Biotechnology

Sektor Healthcare

IPO Datum Jul 31, 2026

Mitarbeiter 65

Börse NasdaqGS

Tickersymbol APMD

Website https://apnimed.com

Vollständiges Unternehmensprofil

Finanzielle Entwicklung

Im Jahr 2025 betrug der Umsatz von Apnimed 38.47 Mio, ein Anstieg von 380.12% im Vergleich zum Vorjahr (8.01 Mio). Der Gewinn lag bei -932K, ein Rückgang von -99.16 %.

Finanzberichte

Nachrichten

vor 4 Tagen · Proactive

Apnimed shares surge on bullish BofA initiation

Shares of Apnimed rose 8% Tuesday after BofA Securities initiated coverage of the company with a Buy rating and a $41 price target. The rating is based on a risk-adjusted discounted cash flow analysis...

vor 5 Tagen · Trefis

Moderna Stock Had A Readout Waiting In Plain Sight

Before the melanoma result, the visible signs were an enrolled trial, a partner paying half its cost, and a market that had stopped pricing an unusually large move.

vor 1 Woche · Trefis

Moderna's Melanoma Result Landed On A Market Positioned The Other Way

The trial met both endpoints in the readout, removing the inconclusive outcome management itself had flagged, and short sellers in the stock took a record single-session loss.

vor 2 Wochen · Simply Wall St.

Apnimed (APMD) Joins The NASDAQ Composite Index

Apnimed (NasdaqGS:APMD) has been added to the NASDAQ Composite Index, increasing its visibility among index-following investors. Inclusion in the index can lead to higher trading liquidity as more fun...

vor 3 Wochen · Investor's Business Daily

Stock Market, IPO Leaders Rally To New Highs. Check This Screen Daily.

Stock market leaders are becoming plentiful as the S&P 500 probes all-time highs. Recent IPO Bending Spoons clears an IPO base.

Apnimed Inc. (APMD)

Über APMD

Finanzielle Entwicklung

Gewinnüberraschung

Warum der Kurs sich bewegte